A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPa) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

FASEB Journal

Volumn 14, Issue 10, 2000, Pages 1400-1410

  Guo, Yongjing ^a   Al Roof Higazi, Abd ^b,c   Arakelian, Ani ^a   Sachais, Bruce S ^b   Cines, Douglas ^a   Goldfarb, Ronald H ^d   Jones, Terence R ^e   Kwaan, H ^f   Mazar, Andrew P ^e,g   Rabbani, Shafaat A ^a,h  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e Angstrom Pharmaceuticals   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Attention LLC   (United States)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Apoptosis; Breast cancer; Endothelial cell; Tumor necrosis

Indexed keywords

AMINO ACID DERIVATIVE; EPITOPE; PEPTIDE DERIVATIVE; UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER INVASION; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; TUMOR CELL; TUMOR GROWTH; TUMOR NECROSIS;

ANIMALIA;

EID: 17544363650     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.10.1400     Document Type: Article

References (7)

1. Mignatti, P., and Rifkin, D. B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195
2. Andreasen, P.A., Kjøller, L., Christensen, L., and Duffy, M. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22
3. Reuning, U., Magdolen, V., Wilhelm, O., Fischer, K., Lutz, V., Graeff, H., and Schmitt, M.1998). Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int. J. Oncol 13, 893-906
4. Mazar, A. P., Henkin, J., and Goldfarb, R. H. (1999) The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 3, 15-32
5. Knoop, A., Andreasen, P. A., Andersen, J. A., Hansen, S., Laenkholm, A. V., Simonsen, A. C., Andersen, J., Overgaard, J., and Rose, C. (1998) Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. Br. J. Cancer. 77, 932-940
6. Schmitt, M., Harbeck, N., Thomssen, C., Wilhelm, O., Magdolen, V., Reuning, U., Ulm, K., Hofler, H., Janicke, F., and Graeff, H. (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb. Haemostasis 78, 285-296
7. Mandriota, S. J., and Pepper, M. S. (1997) Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor 2. J. Cell Sci. 110, 2293-2302